NCT00655746View on ClinicalTrials.gov

The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Healthy
Interventions
DRUG

Dasatinib + Omeprazole

Tablet/Capsule, Oral, (Dasatinib 100 mg)/(Omeprazole 40 mg), once daily, 7 days

Trial Locations (1)

08690

Bristol-Myers Squibb Clinical Pharmacology Unit, Hamilton

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY